On August 29, 2025, the Guangdong-Macao In-Depth Cooperation Zone In Hengqin Enterprise High-Quality Development Conference and the launching ceremony of the “Seedling Cultivation […]
“YX2401K” has been included in the key variety service list Recently, Beletalent (ZHUHAI) Pharmaceutical Co., Ltd. received a notice from the
The Phase III Clinical Trial Launch Meeting of Tangning Tongluo Tablets On January 18, the Phase III clinical trial launch
Case of “Tangning Tongluo Tablets” Exempted from Phase II Clinical Trials Shared On November 21, 2024, the 15th special report
Tangning Tongluo Tablets Approved to Directly Conduct Phase III Clinical Trials On November 12, Beletalent (ZHUHAI) Pharmaceutical Co., Ltd.（hereinafter referred to as Beletalent） received
Beletalent Deepens Exchange with Portuguese-speaking Countries Traditional Medicine Seminar Promote Innovation and Development in the Pharmaceutical Field Recently, the
Guizhou Bailing & MACAO G-RX made a splendid appearance at the International Exhibition on Healthcare, Education, and Sports Opens in Ashgabat
Achievements in the field of innovation of new Chinese medicines From September 7th to 9th, the 2024 Healthy China (Hengqin)
Yindan Xinnaotong Soft Capsules Obtained The Registration And Marketing Authorization For Traditional Chinese Medicine In Brazil. Recently, the overseas registration
MACAO G-RX CO., LTD. On July 9, Beletalent’s subsidiary”MACAO G-RX CO., LTD.“was successfully registered in Macao, and its business scope
